Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Interferon in Pediatric HIV-Related Malignancies
NCT00002621Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Dec 1994
- Primary completion
- Jul 2002
- Modality
- Cytokines & Interferons
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa in malignant neoplasm, sponsored by Children's Oncology Group. Primary endpoint: Complete Response Rate. Started Dec 1994; status: completed.
02
Drugs
interferon alfa
03
Conditions
malignant neoplasm
Beyond the preview
Go deeper on NCT00002621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002621.